Robotic surgery runway remains substantial
Medtronic describes low global robotic-surgery penetration alongside sustained procedure growth, supporting a broad demand-expansion read-through for surgical robotics. The limited emerging-market penetration points to geographic adoption runway rather than a mature replacement-only market.
As robotic-assisted surgery continues to expand, we believe our portfolio breadth, our global reach, and our operating room presence uniquely position us to help shape the future of surgery and extend the benefits of these technologies to more patients around the world. Robotic-assisted surgery, or RAS, is one of the most compelling growth opportunities in healthcare, with global penetration still in the single digits and only 1% in emerging markets. At the same time, RAS is in high demand, with procedure volumes up approximately 16% per year over the last decade. There is a significant runway here, and we expect robust expansion for many years to come.
Who it touches
- MDTbullish
Management cited a substantial runway in robotic-assisted surgery and strong procedure-volume growth.
- ISRGbullish
The quote supports continued category expansion in robotic-assisted surgery, where Intuitive Surgical is a major participant.
About this signal
- Company
- Medtronic plc
- Category
- demand
- Call
- Q1 FY2027